| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥58.6B | ¥56.5B | +3.7% |
| Operating Income | ¥2.0B | ¥-0.1B | +2575.0% |
| Ordinary Income | ¥1.9B | ¥-0.1B | +512.4% |
| Net Income | ¥1.6B | ¥-0.5B | +450.5% |
| ROE | 3.4% | -1.0% | - |
FY2025 Q3 cumulative results show revenue of 5,863 million yen (YoY +3.7%), operating income of 198 million yen (prior year loss of 8 million yen, representing a turnaround from loss to profit), ordinary income of 191 million yen (YoY +512.4%), and net income attributable to owners of 163 million yen (prior year loss of 46 million yen, YoY +450.5%). The company achieved profitability recovery with operating margin of 3.4% and net margin of 2.8%. Basic earnings per share improved to 35.95 yen from prior year loss. Total assets increased to 10,228 million yen from 9,304 million yen, while total equity decreased slightly to 4,858 million yen from 4,882 million yen. Cash and deposits grew substantially by 40.5% to 2,765 million yen, supported by increased long-term borrowings which rose 115.0% to 1,263 million yen. Despite profitability recovery, capital efficiency metrics remain subdued with ROE of 3.4%, ROA of 1.6%, and ROIC of 3.6%.
Revenue growth of 3.7% to 5,863 million yen was driven by balanced expansion across both operating segments and geographic markets. The Industrial Rubber segment recorded sales of 4,428 million yen (up 2.1% from 4,339 million yen prior year), with Japan sales increasing to 3,442 million yen (up 2.5%), Asia sales at 859 million yen (down 4.1%), and North America sales rising to 106 million yen (up 62.7%). The Medical and Hygiene Rubber segment posted sales of 1,435 million yen (up 9.2% from 1,315 million yen), driven by Japan sales of 1,007 million yen (up 3.7%) and strong Asia growth to 428 million yen (up 25.3%). The geographic revenue breakdown shows Japan accounting for 75.9% of total sales, Asia 21.9%, North America 1.8%, and Europe 0.4%, indicating concentrated domestic exposure with emerging international diversification.
Operating income achieved a turnaround from loss of 8 million yen to profit of 198 million yen, driven by segment-level profitability improvements and corporate cost reduction. Corporate expenses decreased to 177 million yen from 209 million yen (down 15.0%), contributing significantly to the operating profit recovery. Gross profit margin remained stable at 24.0% compared to prior year levels. The operating margin of 3.4% reflects early-stage profitability recovery but remains at industry benchmark caution levels.
The gap between operating income (198 million yen) and ordinary income (191 million yen) was minimal at 7 million yen, comprising non-operating income of 21 million yen (including dividend income of 6 million yen and interest income of 4 million yen) offset by non-operating expenses of 28 million yen (primarily interest expense of 13 million yen). The increase in interest expense from prior year reflects the impact of expanded borrowings. Net income reached 163 million yen after extraordinary income of 29 million yen and income taxes of 51 million yen (effective tax rate 23.9%). The extraordinary income represents a non-recurring factor that augmented bottom-line results.
This represents a revenue growth with profit recovery pattern. The company transitioned from operational losses to profitability through both top-line growth and cost structure optimization, though the sustainability of margin expansion warrants monitoring given the contribution from non-recurring items and limited operating leverage at current scale.
The Industrial Rubber segment generated revenue of 4,428 million yen (75.5% of total revenue) and operating income of 262 million yen, representing the core business with operating margin of 5.9%. This segment achieved substantial profit improvement from 88 million yen in the prior year (up 197.3%), driven by margin expansion despite modest revenue growth of 2.1%. The profitability recovery primarily reflects improved operational efficiency and favorable product mix, particularly with North American sales nearly doubling.
The Medical and Hygiene Rubber segment recorded revenue of 1,435 million yen (24.5% of total revenue) and operating income of 113 million yen, yielding an operating margin of 7.9%. This segment demonstrated stable profitability with operating income essentially flat at 112 million yen prior year, while achieving stronger revenue growth of 9.2%. The higher margin profile compared to Industrial Rubber reflects the specialized nature and value proposition of medical and hygiene applications.
Before corporate cost allocation, combined segment profit reached 375 million yen, reduced to consolidated operating income of 198 million yen after deducting corporate expenses of 177 million yen. The material margin differential between segments suggests strategic potential in shifting portfolio mix toward higher-margin Medical and Hygiene applications, while the Industrial Rubber segment's larger scale provides volume leverage. The 15% reduction in corporate costs represents a key driver of consolidated profitability recovery and indicates management focus on operational efficiency.
[Profitability] ROE of 3.4% represents recovery from prior year losses but remains below the manufacturing industry median of 5.2%. Operating margin of 3.4% falls short of industry median of 8.7%, positioning in the lower quartile and indicating room for improvement in cost structure efficiency. Net profit margin of 2.8% compares to industry median of 6.4%, reflecting early-stage profitability recovery. Gross profit margin maintained at 24.0% demonstrates pricing discipline and production efficiency. ROIC of 3.6% (vs. industry median of 6.0%) indicates suboptimal capital deployment efficiency. [Cash Quality] Cash and equivalents of 2,765 million yen provide strong short-term debt coverage ratio of 3.5x against short-term borrowings of 800 million yen. Operating working capital increased, with accounts receivable at 1,543 million yen (DSO 97 days vs. industry median 83 days) and inventories at 1,242 million yen (DIO 102 days vs. industry median 109 days), resulting in cash conversion cycle of 172 days that warrants monitoring for working capital efficiency. [Investment Efficiency] Asset turnover of 0.573 aligns with industry median of 0.58, indicating comparable asset productivity. Total assets of 10,228 million yen with revenue of 5,863 million yen (annualized basis approximately 7,817 million yen) yield stable asset utilization. [Financial Health] Equity ratio of 47.5% compares favorably to industry median of 63.8%, though indicates relatively higher financial leverage. Current ratio of 194.6% substantially exceeds industry median of 283%, demonstrating adequate but not excessive liquidity positioning. Debt-to-equity ratio of 1.11 and interest-bearing debt of 2,063 million yen against equity of 4,858 million yen reflect conservative capital structure. Financial leverage of 2.11x aligns with industry median of 1.53x, indicating moderate balance sheet leverage utilized to support operations.
Cash and deposits increased 797 million yen YoY to 2,765 million yen, representing a 40.5% expansion that substantially strengthens liquidity position. This cash accumulation occurred alongside operating profit recovery to 198 million yen and receipt of extraordinary income of 29 million yen, contributing to cash generation. Working capital movements show accounts receivable increasing 119 million yen to 1,543 million yen, reflecting revenue growth but also indicating elongated collection cycles with DSO of 97 days. Inventories rose 56 million yen to 1,242 million yen, aligned with production scaling though DIO of 102 days suggests inventory management efficiency opportunities. Accounts payable decreased 125 million yen to 943 million yen, representing reduced supplier credit utilization that consumed cash, with DPO declining to 73 days from prior levels. The net working capital increase absorbed operating cash, evidenced by cash conversion cycle extending to 172 days. On the financing side, long-term borrowings increased substantially by 675 million yen from 588 million yen to 1,263 million yen, representing a strategic shift toward term debt financing that provided major cash inflows. Short-term borrowings remained stable at 800 million yen. The combination of operating profit recovery, working capital buildup, and debt financing expansion explains the material cash position growth. Investment activities are inferred to be moderate given total asset increase of 924 million yen primarily reflecting current asset expansion rather than major capital expenditure. Cash coverage of short-term liabilities stands at 3.5x against short-term borrowings specifically, and 0.91x against total current liabilities of 3,040 million yen, indicating adequate near-term liquidity though working capital optimization would further strengthen cash resilience.
Ordinary income of 191 million yen versus operating income of 198 million yen shows modest net non-operating expense of 7 million yen, indicating core earnings derive primarily from operations. Non-operating income totaled 21 million yen, comprising dividend income of 6 million yen, interest income of 4 million yen, and other items, representing routine investment returns. Non-operating expenses of 28 million yen consisted mainly of interest expense of 13 million yen related to borrowings, with the year-over-year increase reflecting expanded debt levels. Non-operating items represented 0.5% of revenue, a minimal proportion that confirms earnings are predominantly operationally driven. The company recorded extraordinary income of 29 million yen, a non-recurring item that augmented pre-tax income to 215 million yen from ordinary income of 191 million yen. This extraordinary gain represents approximately 15% of pre-tax income and should be adjusted for in assessing sustainable earnings power. After income taxes of 51 million yen (effective rate 23.9%), net income reached 163 million yen. The operating cash flow details are not disclosed for the quarterly period, preventing direct assessment of cash earnings quality through operating CF to net income comparison. However, the substantial cash balance increase of 797 million yen against net income of 163 million yen suggests cash accumulation exceeded reported earnings, though this includes financing cash inflows from borrowing expansion. The working capital deterioration evidenced by extended DSO and DIO indicates potential accruals buildup, warranting scrutiny of whether revenue and profit growth translates to proportionate cash generation. Overall earnings quality is supported by operating profit recovery and minimal non-operating distortions, but the contribution from extraordinary income and absence of operating cash flow disclosure limit full assessment of earnings sustainability and cash backing.
Full-year guidance projects revenue of 7,829 million yen, operating income of 202 million yen, ordinary income of 191 million yen, and net income of 154 million yen. Against Q3 cumulative results of 5,863 million yen revenue (74.9% progress rate vs. standard 75%), 198 million yen operating income (98.0% progress), 191 million yen ordinary income (100% progress), and 163 million yen net income (105.8% progress), the company has essentially achieved or exceeded full-year profit targets by Q3. Revenue progress of 74.9% is slightly below the standard Q3 rate of 75%, suggesting modest Q4 revenue contribution of approximately 1,966 million yen is anticipated, representing 33.5% of cumulative Q3 revenue. Operating income progress at 98.0% indicates Q4 operating income guidance of merely 4 million yen, implying near-zero incremental profit generation in the final quarter. Net income has already surpassed full-year guidance by 9 million yen, though this reflects the extraordinary income of 29 million yen recorded in Q3 that may not have been fully incorporated in initial guidance assumptions. The substantial profit realization by Q3 suggests either conservative initial guidance setting or front-loaded profitability with anticipated Q4 margin compression from seasonal factors, increased costs, or strategic investments. Full-year operating margin is guided at 2.6% (202 million yen on 7,829 million yen revenue), lower than Q3 cumulative margin of 3.4%, confirming expectation of Q4 margin deterioration. Year-over-year guidance indicates revenue growth of 2.5% and ordinary income growth of 512.4% from prior year levels, with the profit growth driven by the turnaround from prior year losses. The limited incremental profit contribution expected in Q4 warrants attention to whether seasonal patterns, competitive pressures, or cost timing factors are anticipated to compress margins in the final quarter.
Annual dividend is projected at 20 yen per share, comprising interim dividend of 10 yen and year-end dividend of 10 yen. Comparing to prior year dividend of 20 yen per share, the dividend is maintained at a stable level despite the significant earnings recovery. Based on full-year guidance of net income 154 million yen and approximately 4.5 million shares outstanding (inferred from EPS guidance of 34.32 yen), total dividend payout would approximate 90 million yen, yielding payout ratio of 58.4% against guided earnings. Using actual Q3 cumulative net income of 163 million yen and annualized basis, the payout ratio calculates to approximately 56.7%, which positions in the upper range of sustainable dividend benchmarks. The payout ratio above 50% indicates shareholder-friendly capital allocation, though sustainability depends on earnings stability and cash flow generation given the recent return to profitability. No share buyback programs are disclosed in the available data. The total return ratio equals the payout ratio at approximately 57-58% in absence of buybacks. Treasury stock increased by 52 million yen to 86 million yen (book value), representing continued share repurchases or employee share-related transactions, though the scale is relatively modest. The maintenance of 20 yen dividend through the prior loss period and current recovery phase demonstrates dividend policy commitment, though the elevated payout ratio and absence of operating cash flow disclosure create uncertainty regarding dividend coverage from free cash flow. With cash reserves of 2,765 million yen providing substantial buffer and low current payout in absolute terms (approximately 90 million yen annually), near-term dividend sustainability appears secure, but medium-term sustainability requires confirmation of operating cash flow generation exceeding dividend requirements plus necessary capital expenditure.
Working capital deterioration poses the primary risk, with receivables turnover extending to 97 days (vs. industry median 83 days) and inventory days at 102 days creating cash conversion cycle of 172 days. This indicates potential customer payment delays or intentional inventory buildup, either of which could constrain operating cash flow generation and necessitate additional external financing despite reported profitability. If working capital efficiency fails to improve, the company may face cash flow pressures that limit financial flexibility and dividend sustainability despite adequate current cash reserves.
Low operating margins of 3.4% (vs. industry median 8.7%) and ROIC of 3.6% (vs. industry median 6.0%) indicate vulnerability to operational headwinds and competitive pressures. The limited margin cushion means minor revenue shortfalls or cost increases could quickly erode profitability. Fourth quarter guidance implies near-zero incremental operating profit on approximately 1,966 million yen Q4 revenue, suggesting expected margin compression to approximately 0.2%, which raises questions about seasonal cost patterns or pricing pressures that could persist into subsequent periods.
Debt expansion risk emerges from long-term borrowings increasing 115% to 1,263 million yen, which doubled the prior year level. While current debt ratios remain manageable with debt-to-equity of 1.11 and interest coverage adequate, the rapid leverage increase indicates potential strategic shift toward debt-financed growth or working capital funding. Interest expense rose to 13 million yen, and further rate increases or refinancing at less favorable terms could pressure net income. The combination of elevated borrowing, working capital absorption, and uncertain operating cash flow generation creates refinancing risk if profitability fails to strengthen or asset efficiency deteriorates further.
[Industry Position] (Reference - Proprietary Analysis)
Profitability metrics show the company underperforming manufacturing sector medians. ROE of 3.4% falls below industry median of 5.2% (Q3 2025, n=100), positioning in the lower half of the sector and indicating room for improvement in capital efficiency. Operating margin of 3.4% significantly trails industry median of 8.7% (IQR: 5.1%-12.6%), placing the company in the bottom quartile for operational profitability. Net profit margin of 2.8% compares unfavorably to sector median of 6.4% (IQR: 3.3%-9.3%), reflecting both operational margin gaps and effective tax burden. ROIC of 3.6% versus industry median of 6.0% confirms suboptimal invested capital returns.
Financial health indicators present mixed positioning. Equity ratio of 47.5% is below industry median of 63.8% (IQR: 49.4%-74.5%), indicating higher financial leverage than typical peers though remaining within the interquartile range. Current ratio of 194.6% falls short of industry median of 283% (IQR: 211%-380%), suggesting relatively tighter liquidity positioning despite absolute adequacy. The company's financial leverage of 2.11x exceeds sector median of 1.53x (IQR: 1.31-1.86), consistent with the lower equity ratio and reflecting more aggressive capital structure utilization.
Efficiency metrics show competitive asset turnover but challenged working capital management. Asset turnover of 0.573 aligns closely with industry median of 0.58 (IQR: 0.41-0.66), indicating comparable productivity in generating revenue from asset base. However, receivables turnover of 97 days exceeds sector median of 83 days (IQR: 68-114 days), signaling collection efficiency challenges. Inventory turnover of 102 days compares favorably to median of 109 days (IQR: 50-155 days), suggesting adequate inventory management despite absolute levels warranting optimization. Operating working capital cycle of 172 days versus sector median of 108 days (IQR: 71-143 days) positions the company in the upper quartile for working capital intensity, representing a key efficiency gap.
Growth metrics demonstrate modest but positive momentum. Revenue growth of 3.7% exceeds industry median of 2.8% (IQR: -1.7% to 8.1%), positioning in the upper half of peers for top-line expansion. EPS growth of 450% (base effect from prior year loss) versus median of 6% (IQR: -25% to 31%) reflects the profitability recovery but is not sustainable at this magnitude.
Overall, the company exhibits below-median profitability and capital efficiency relative to manufacturing sector peers, with particular gaps in operating margins and ROIC. Working capital intensity significantly exceeds sector norms, representing the primary operational efficiency challenge. Financial leverage is higher than median but within reasonable bounds, while liquidity remains adequate. Growth momentum slightly exceeds sector averages from a low base. The industry comparison highlights margin expansion and working capital optimization as critical priorities to achieve peer-level performance.
(Industry: Manufacturing Sector, Comparison: Q3 2025 fiscal periods, Source: Proprietary analysis of publicly disclosed financial data, n=100 manufacturing companies)
Profitability recovery marks a significant inflection point, with the company achieving operating profit turnaround from 8 million yen loss to 198 million yen profit and returning to net income of 163 million yen from prior year loss of 46 million yen. This recovery was driven by both revenue growth of 3.7% and corporate cost reduction of 15%, demonstrating operational improvements are taking effect. However, operating margin of 3.4% and ROIC of 3.6% remain materially below manufacturing sector medians of 8.7% and 6.0% respectively, indicating early-stage recovery with substantial further improvement required to achieve competitive profitability levels. The contribution of 29 million yen extraordinary income (representing 18% of net income) to bottom-line results highlights the importance of distinguishing sustainable operating performance from non-recurring benefits in assessing ongoing earnings power.
Working capital efficiency deterioration represents the most critical operational concern, with cash conversion cycle extending to 172 days versus industry median of 108 days, driven by receivables days of 97 (vs. median 83) and inventory days of 102 (vs. median 109). This working capital intensity has implications for cash flow quality despite reported profitability, as approximately 175 million yen is tied up in incremental working capital expansion based on balance sheet movements. The absence of disclosed operating cash flow data for the quarterly period limits visibility into whether profit growth is translating to proportionate cash generation, though the working capital trends suggest potential cash conversion challenges that warrant close monitoring in subsequent reporting periods.
Financial structure shift toward increased leverage merits attention, with long-term borrowings more than doubling from 588 million yen to 1,263 million yen (up 675 million yen or 115%). While debt ratios remain manageable with debt-to-equity of 1.11 and net debt to EBITDA estimated at moderate levels, the rapid leverage increase combined with working capital absorption suggests the cash balance growth of 797 million yen was substantially funded by external debt rather than organic cash generation. Interest expense increased to 13 million yen annually, and the sustainability of margin expansion could be tested if borrowing costs rise or if the incremental capital deployed fails to generate adequate returns. Fourth quarter guidance implying near-zero incremental operating profit raises questions about margin sustainability and whether the Q1-Q3 profitability recovery can be maintained through operational execution rather than one-time cost reductions or favorable non-recurring items.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.